Literature DB >> 19590871

Percutaneous ablation for bone and soft tissue metastases--why cryoablation?

Matthew R Callstrom1, A Nick Kurup.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19590871     DOI: 10.1007/s00256-009-0736-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  15 in total

Review 1.  Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Thomas D Atwell; Michael A Farrell; Timothy J Welch; Timothy P Maus
Journal:  Skeletal Radiol       Date:  2005-10-05       Impact factor: 2.199

2.  Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.

Authors:  Matthew R Callstrom; Thomas D Atwell; J William Charboneau; Michael A Farrell; Matthew P Goetz; Joseph Rubin; Jeff A Sloan; Paul J Novotny; Timothy J Welch; Timothy P Maus; Gilbert Y Wong; Kathy J Brown
Journal:  Radiology       Date:  2006-11       Impact factor: 11.105

3.  The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group.

Authors:  D Tong; L Gillick; F R Hendrickson
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

Review 4.  Bone metastases: pathophysiology and management policy.

Authors:  O S Nielsen; A J Munro; I F Tannock
Journal:  J Clin Oncol       Date:  1991-03       Impact factor: 44.544

5.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

6.  Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.

Authors:  Matthew P Goetz; Matthew R Callstrom; J William Charboneau; Michael A Farrell; Timothy P Maus; Timothy J Welch; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Ivy A Petersen; Robert A Beres; Daniele Regge; Rodolfo Capanna; Mark B Saker; Dietrich H W Grönemeyer; Athour Gevargez; Kamran Ahrar; Michael A Choti; Thierry J de Baere; Joseph Rubin
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

7.  Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Bradley D Lewis; Timothy J Welch; Michael A Farrell; Timothy P Maus; Robert A Lee; Carl C Reading; Ivy A Petersen; Deitra D Pickett
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

8.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

9.  Osteoid osteoma: percutaneous treatment with radiofrequency energy.

Authors:  Daniel I Rosenthal; Francis J Hornicek; Martin Torriani; Mark C Gebhardt; Henry J Mankin
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

10.  Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

Authors:  D I Rosenthal; F J Hornicek; M W Wolfe; L C Jennings; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1998-06       Impact factor: 5.284

View more
  24 in total

1.  Cryosurgery/cryoablation in musculoskeletal neoplasms: history and state of the art.

Authors:  Peter S Rose; Jonathan M Morris
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

Review 2.  Thermal Ablation of Bone Metastases.

Authors:  Michael R Moynagh; A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

Review 3.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

Review 4.  Benign Spine Lesions: Advances in Techniques for Minimally Invasive Percutaneous Treatment.

Authors:  A Tomasian; A N Wallace; J W Jennings
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-09       Impact factor: 3.825

Review 5.  Technical and practical considerations for device selection in locoregional ablative therapy.

Authors:  Sean P Zivin; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

6.  Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patients.

Authors:  Michael David Lane; Huy B Q Le; Steven Lee; Casey Young; Manraj K S Heran; Maziar Badii; Paul William Clarkson; Peter L Munk
Journal:  Skeletal Radiol       Date:  2010-08-05       Impact factor: 2.199

7.  Percutaneous cryoablation for the treatment of osteoid osteoma in the adult population.

Authors:  Elodie Santiago; Vanessa Pauly; Gilles Brun; Daphné Guenoun; Pierre Champsaur; Thomas Le Corroller
Journal:  Eur Radiol       Date:  2018-01-02       Impact factor: 5.315

8.  CT-guided percutaneous cryoablation of osteoid osteoma in children: an initial study.

Authors:  Bin Wu; Yue-Yong Xiao; Xiao Zhang; Lei Zhao; John A Carrino
Journal:  Skeletal Radiol       Date:  2011-02-12       Impact factor: 2.199

9.  Image-guided percutaneous ablation of bone and soft tissue tumors.

Authors:  A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

10.  Image-guided tumor ablation: emerging technologies and future directions.

Authors:  Justin P McWilliams; Edward W Lee; Shota Yamamoto; Christopher T Loh; Stephen T Kee
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.